The Fund aims to achieve medium to long term capital appreciation. The Fund will invest in Shariah-compliant equities (up to 98% of its NAV) listed in Asia Pacific countries, excluding Malaysia and India, where the regulatory authorities are the ordinary or associate members of the International Organization of Securities Commissions (IOSCO). The Fund provides the investor with the opportunity to invest in a diversified portfolio of Shariah-compliant equities, which integrates UNGC, ESG and fundamental analysis and offers long-term capital appreciation opportunities.
BIMB-Arabesque Asia Pacific Shariah-ESG Equity MYR
Latest Price NAV
USD
0.05
as of
12/Sep/23
Objective
Performance
3 Yrs Performance
-5.95
5 Yrs Performance
-4.84
10 Yrs Performance
N.A
Top Holdings
1.
Morinaga & Co. Ltd
3.52
%
2.
Kalbe Farma Tbk PT
3.47
%
3.
H.U. Group Holdings Inc
3.35
%
4.
Sundrug Co. Ltd
3.26
%
5.
Cheil Worldwide Inc.
3.22
%
6.
IPH LTD
2.87
%
7.
Rohto Pharmaceutical Co. Ltd
2.86
%
8.
Cochlear Limited
2.82
%
9.
Mega Lifesciences Pcl
2.74
%
10.
Pt Akr Corporindo Tbk
2.65
%
Portfolio Composition
1.
Japan
57.02
%
2.
Australia
12.63
%
3.
Taiwan
9.22
%
4.
Korea
7.23
%
5.
Indonesia
6.13
%
6.
Thailand
4.4
%
7.
Hong Kong
2.17
%
8.
Singapore
2.12
%
9.
Cash & Cash Equivalents
-0.93
%
Transaction Information
Annual Charges
Minimum Charge :
N.A
Maximum Charge:
1.8
Initial Charges
Minimum Charge :
N.A
Maximum Charge :
5.5
Actual Charge :
N.A
Redemption Charges
Minimum Charge :
N.A
Maximum Charge:
N.A
Actual Charge :
N.A
Contact
Company Name:
BIMB Invest
Website :
http://www.bimbinvestment.com.my/